Cc1nn(C)c(C)c1S(=O)(=O)N(CC(=O)NCCCN1CCC(C)CC1)c1ccc(C(C)C)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?